-
Awarded27/03/2025
-
Today30/04/2025
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Contract award notice on the basis of Article 266a(5)(3) of the Medicinal Products in Human Medicine Act, in conjunction with Article 1(1)(2), Article 3(3), Article 15c(1) and Article 15b of Regulation No 10/17.11.2011 of the Ministry of Health Text automatically translated in your browsing language Automatically translated
The Contractor agrees, after receiving a letter of agreement from the Bulgarian Drug Agency (BDA) and a written request for delivery of the following medicinal product, to deliver the following medicinal product in the quantities prescribed by UMBALSM N. I. Pirogov EAD with protocol – Annex No 1 or No 2 (whichever is applicable), issued in accordance with Regulation No 10/17.11.2011, on the offer of the CONTRACTOR. - International non-proprietary name/INN/Triamcinolone acetonide 40 mg/ml solution for injection amp./ Trade name-KENACORT - ampoule, 100 pieces; - International non-proprietary name/INN/Etomidate/ Trade name-HYPNOMIDATE-ampoule, 200 pieces; -International non-proprietary name/INN/Rocuronium/Trade name-ROCURONIUM ROMPHARM-ampoule, 3640 pieces; Text automatically translated in your browsing language Automatically translated
33600000 - Pharmaceutical products
33690000 - Various medicinal products CVP code deduced from the text of the procedure AI-generated
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.